OÜ Antegenes
OÜ Antegenes is a OÜ based in Tartu linn, registry code 14489312, status: active. Main activity: Medical specialists activities. According to EMTA, turnover for Q3 2026 was €109 668 with 10 employees.
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 109 668 €above 92% of companiesindustry median 9 428 € · companies in the industry: 351
- Labour taxes per employee 4 492 €above 83% of companiesindustry median 2 177 € · companies in the industry: 1 696
- Revenue · 2025 431 884 €above 87% of companiesindustry median 20 811 € · companies in the industry: 3 373
- Net profit margin · 2025 -54.2 %above 2% of companiesindustry median 8.3 % · companies in the industry: 2 759
Taxes and turnover
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 109 668 | 56 753 | 44 916 | 10 |
| Q2 2026 | 142 918 | 57 386 | 42 238 | 10 |
| Q1 2026 | 119 689 | 55 557 | 37 451 | 10 |
| Q4 2025 | 103 251 | 56 608 | 42 216 | 8 |
| Q3 2025 | 113 650 | 70 520 | 57 908 | 8 |
| Q2 2025 | 111 116 | 62 150 | 52 096 | 11 |
| Q1 2025 | 103 073 | 65 110 | 55 057 | 11 |
| Q4 2024 | 97 948 | 77 532 | 69 970 | 11 |
| Q3 2024 | 90 866 | 72 326 | 69 987 | 18 |
| Q2 2024 | 63 340 | 77 153 | 78 274 | 17 |
| Q1 2024 | 11 911 | 69 189 | 73 843 | 17 |
| Q4 2023 | 79 789 | 65 024 | 65 253 | 18 |
| Q3 2023 | 121 048 | 65 073 | 59 280 | 15 |
| Q2 2023 | 99 228 | 70 467 | 66 131 | 14 |
| Q1 2023 | 26 042 | 52 406 | 54 345 | 16 |
| Q4 2022 | 33 523 | 45 353 | 45 160 | 18 |
| Q3 2022 | 15 285 | 33 350 | 35 748 | 17 |
| Q2 2022 | 4 952 | 27 748 | 29 328 | 12 |
| Q1 2022 | 7 263 | 26 533 | 27 020 | 10 |
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 431 884 | -233 904 | 450 257 | 885 913 | 451 061 | 8 |
| 2024 | 212 068 | -828 607 | 743 769 | 375 349 | 260 921 | 14 |
| 2023 | 170 880 | -768 463 | 726 546 | 1 161 440 | 591 765 | 14 |
| 2022 | 33 570 | -698 196 | 388 653 | 1 690 137 | 1 360 229 | 11 |
| 2021 | 187 384 | -170 563 | 210 817 | 428 819 | 383 383 | 7 |
| 2020 | 19 123 | -168 596 | 159 684 | 265 485 | 53 946 | 5 |
| 2019 | 1 045 | -18 954 | 81 097 | 175 811 | -26 833 | 2 |
| 2018 | — | — | — | — | — | 1 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 30 Mar 2026 | Company’s own | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 2 Apr 2025 | Company’s own | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 31 May 2024 | Company’s own | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 1 Jun 2023 | Company’s own | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 8 Apr 2022 | Company’s own | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 17 Jun 2021 | Company’s own | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 14 Apr 2020 | Company’s own | e-Äriregister |
Board
- Peeter PadrikBoard member · since 15 May 2018
- Berit KolkBoard member · since 9 May 2019
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- OÜ PersonaalmeditsiinLegal person · 11221767 · 1 825 €
- RD Kinnisvara OÜLegal person · 12520851 · 639 €
- EVERYTHING GENETIC LTDLegal person · 147 €
- Einberi OÜLegal person · 10843308 · 114 €
- Biogenoma OÜLegal person · 14849638 · 75 €
- Berit KolkNatural person · 75 €
- 12 Capital OÜLegal person · 12211570 · 72 €
- Forestec Eesti OÜLegal person · 11980355 · 72 €
- Rochna Invest OÜLegal person · 16154403 · 72 €
- Vain OÜLegal person · 10324593 · 72 €
- Einberi OÜLegal person · 10843308 · 57 €
- Roman SilkNatural person · 36 €
- Osaühing MersokLegal person · 10508811 · 29 €
- Tarmo-Tanel PadrikNatural person · 25 €
- Astronaut OÜLegal person · 11199447 · 21 €
- Jagnar PindmaaNatural person · 18 €
- Siim SõberNatural person · 18 €
- Arbuust OÜLegal person · 16210277 · 14 €
- Brugal Invest OÜLegal person · 12629016 · 14 €
- Eiki RumpNatural person · 14 €
- SIA Eska TradingLegal person · 14 €
- Uniment Health OÜLegal person · 16326531 · 14 €
- Anna PadrikNatural person · 9 €
- Regina SaarNatural person · 9 €
- Anette PaasNatural person · 7 €
Beneficial owners
- Peeter PadrikIndirect ownership · since 30 Sep 2018
Founders and other persons
- OÜ PersonaalmeditsiinFounder · 2 500 € · 15 May 2018
Related companies
Activities (EMTAK)
- 86221Medical specialists activities Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 50094263 / 24 8 Jul 2026 |
Amendment entry | In force 8 Jul 2026 |
||
| Ä 50094263 / 23 7 May 2026 |
Amendment entry | In force 7 May 2026 |
||
| Ä 50094263 / M3 6 May 2026 |
Ruling to eliminate deficiencies | 21 May 2026 | Deficiencies eliminated 7 May 2026 |
|
| Ä 50094263 / 22 4 May 2026 |
Entry refused: deficiencies not eliminated | In force 20 May 2026 |
||
| Ä 50094263 / 21 22 Apr 2026 |
Amendment entry | In force 22 Apr 2026 |
||
| Ä 50094263 / M2 15 Apr 2026 |
Ruling to eliminate deficiencies | 30 Apr 2026 | In force 30 Apr 2026 |
|
| Ä 50094263 / 20 10 Nov 2025 |
Amendment entry | In force 10 Nov 2025 |
||
| Ä 50094263 / 19 21 Oct 2024 |
Amendment entry | In force 21 Oct 2024 |
||
| Ä 50094263 / 18 1 Dec 2023 |
Amendment entry | In force 1 Dec 2023 |
||
| Ä 50094263 / 17 1 Sep 2023 |
Amendment entry | In force 1 Sep 2023 |
||
| Ä 50094263 / 16 28 Sep 2022 |
Amendment entry | In force 28 Sep 2022 |
||
| Ä 50094263 / 15 17 Jul 2022 |
Amendment entry | In force 17 Jul 2022 |
||
| Ä 50094263 / 14 14 Jun 2022 |
Amendment entry | In force 14 Jun 2022 |
||
| Ä 50094263 / 13 9 Nov 2021 |
Amendment entry | In force 9 Nov 2021 |
||
| Ä 50094263 / 12 13 Oct 2021 |
Amendment entry | In force 13 Oct 2021 |
||
| Ä 50094263 / 11 5 Oct 2021 |
Amendment under Commercial Code § 525 (2) | In force 5 Oct 2021 |
||
| Ä 50094263 / 10 28 May 2021 |
Amendment entry | In force 28 May 2021 |
||
| Ä 50094263 / M1 27 May 2021 |
Ruling to eliminate deficiencies | 16 Jun 2021 | Deficiencies eliminated 28 May 2021 |
|
| Ä 50094263 / 9 3 Apr 2020 |
Amendment entry | In force 3 Apr 2020 |
||
| Ä 50094263 / 8 23 Mar 2020 |
Amendment entry | In force 23 Mar 2020 |
||
| Ä 50094263 / 7 31 Jan 2020 |
Amendment under Commercial Code § 525 (2) | In force 31 Jan 2020 |
||
| Ä 50094263 / 6 9 May 2019 |
Amendment entry | In force 9 May 2019 |
||
| Ä 50094263 / 5 18 Mar 2019 |
Amendment entry | In force 18 Mar 2019 |
||
| Ä 50094263 / 4 1 Oct 2018 |
Amendment under Commercial Code § 525 (2) | In force 1 Oct 2018 |
||
| Ä 50094263 / 3 16 Aug 2018 |
Amendment entry | In force 16 Aug 2018 |
||
| Ä 50094263 / 2 18 Jul 2018 |
Amendment entry | In force 18 Jul 2018 |
||
| Ä 50094263 15 May 2018 |
First entry | In force 15 May 2018 |
Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data